![Kathy Nielsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Kathy Nielsen has over 20 years in medical research, technology transfer and commercialisation - developing early stage technologies in the life sciences sector, with a focus on new therapeutics.
She has identified and developed new products over diverse fields including biotechnology, medicinal chemistry, peptide technologies, natural products, stem cell technology, cleantech and nanotechnology.
With expertise in intellectual property, a solid scientific background derived from several years in academia and significant industry experience (pharmaceutical and biotechnology), Dr. Nielsen has driven inventive concepts through to high quality investment ready propositions and has played key roles in the establishment, fund raising and early stage operations for several start-up companies.
Her recent roles include Director of Intellectural Property (Xenome Ltd), Executive Officer and Director (ElaCor Pty Ltd) and Manager, Intellectual Property and Development (IMBcom Pty Ltd).
| Unternehmen | Position | Ende |
|---|---|---|
Relevare Pharmaceuticals Ltd.
 Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development of novel therapies to treat chronic and acute pain | Direktor/Vorstandsmitglied | - |
Relevare Aust Pty Ltd.
 Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative methods to treat diseases | Direktor/Vorstandsmitglied | - |
Verva Pharmaceuticals Ltd.
 Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies to treat diabetes | Direktor/Vorstandsmitglied | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
| PROTAGONIST THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Queensland BioCapital Funds Pty Ltd.
 Queensland BioCapital Funds Pty Ltd. Investment ManagersFinance QBF invests in Australian companies in the life sciences and biotechnology sectors including drug development, medical devices and information technology for biosciences research. They invest in seed to mezzanine stage, specializing in companies in which QBF has contacts and technical expertise.They provides financing for early stage & expansion capital requirements with an investment size ranging from AUD $5 to AUD$15 million. QBF makes co-investments. | Finance |
Relevare Aust Pty Ltd.
Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative methods to treat diseases | Health Technology |
Verva Pharmaceuticals Ltd.
Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies to treat diabetes | Health Technology |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development of novel therapies to treat chronic and acute pain | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
